The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
SLC19A1 is an importer of the immunotransmitter cGAMP.
Open accessPublished version of a preprint
Abstract
2'3'-cyclic-GMP-AMP (cGAMP) is a second messenger that activates the antiviral stimulator of interferon genes (STING) pathway. We recently identified a novel role for cGAMP as a soluble, extracellular immunotransmitter that is produced and secreted by cancer cells. Secreted cGAMP is then sensed by host cells, eliciting an antitumoral immune response. Due to the antitumoral effects of cGAMP, other CDN-based STING agonists are currently under investigation in clinical trials for metastatic solid tumors. However, it is unknown how cGAMP and other CDNs cross the cell membrane to activate intracellular STING. Using a genome-wide CRISPR screen, we identified SLC19A1 as the first known importer of cGAMP and other CDNs, including the investigational new drug 2'3'-bisphosphosphothioate-cyclic-di-AMP (2'3'-CDA S). These discoveries will provide insight into cGAMP's role as an immunotransmitter and aid in the development of more targeted CDN-based cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Interestingly, cGAMP is also secreted from cancer cells via SLC19A1, which induces activation of the STING pathway in recipient cells.78, 79”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [78]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Using a genome wide CRISPR interference screen, SLC19A1, was identified as the first known major importer of cGAMP, which is taken up by host cells to activate intracellular STING pathway to elicit an antitumor immune response.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ritchie et al., 2019
In the citing paper
“Recently, a novel role of cGAMP as a soluble extracellular immunotransmitter produced and secreted by malignant cells has been identified.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ritchie et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. M. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,220
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752
Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
STING is a direct innate immune sensor of cyclic di-GMP
Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10429 · Cited by 1,570
Cited by
Sorted by citations
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
McLaughlin, M., Patin, E. C., Pedersen, M., Wilkins, A. C., Dillon, M. T., Melcher, A. A., & Harrington, K. J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0246-1 · Cited by 921
Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway
Zhang, X., Bai, X., & Chen, Z. J. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.013 · Cited by 859
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 811
The cGAS–STING pathway and cancer
Samson, N., & Ablasser, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00468-w · Cited by 740
Improving cancer immunotherapy through nanotechnology
Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 622
Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway
Kim, J., Kim, H., & Chung, J. H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00965-7 · Cited by 594
Zhou, Y., Fei, M., Zhang, G., Liang, W., Lin, W., Wu, Y., Piskol, R., Ridgway, J. B., McNamara, E., Huang, H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.014 · Cited by 406
Wu, J., Dobbs, N., Yang, K., & Yan, N. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.009 · Cited by 373
Carozza, J. A., Böhnert, V., Nguyen, K. C., Skariah, G. M., Shaw, K. E., Brown, J. A., Rafat, M., von Eyben, R., Graves, E. E., Glenn, J. S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0028-4 · Cited by 375
Self-citationChemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 372
New frontiers in the cGAS-STING intracellular DNA-sensing pathway
Dvorkin, S., Cambier, S., Volkman, H. E., & Stetson, D. B. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.019 · Cited by 390
Regulation of cGAS- and RLR-mediated immunity to nucleic acids
Ablasser, A., & Hur, S. (2019) · Nature Immunology · doi:10.1038/s41590-019-0556-1 · Cited by 339
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Zheng, J., Mo, J., Zhu, T., Zhuo, W., Yi, Y., Hu, S., Yin, J., Zhang, W., Zhou, H., & Liu, Z. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01250-1 · Cited by 344
Signaling by cGAS–STING in Neurodegeneration, Neuroinflammation, and Aging
Paul, B. D., Snyder, S. H., & Bohr, V. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.008 · Cited by 336
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja‐Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 318
Zhou, C., Chen, X., Planells‐Cases, R., Chu, J., Wang, L., Cao, L., Li, Z., López‐Cayuqueo, K. I., Xie, Y., Ye, S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.016 · Cited by 295
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
Zhang, Z., & Zhang, C. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01112-7 · Cited by 287
Cytosolic DNA sensing by cGAS: regulation, function, and human diseases
Yu, L., & Liu, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00554-y · Cited by 295
Pulido, Á. D. M., Hänggi, K., Celias, D. P., Gardner, A., Li, J., Bittencourt, B. M. B., Mohamed, E. T., Trillo-Tinoco, J., Osunmakinde, O., Peña, R. J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.019 · Cited by 282
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Wan, D., Jiang, W., & Hao, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00615 · Cited by 270
NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
Nicolai, C. J., Wolf, N., Chang, I.-C., Kirn, G., Marcus, A., Ndubaku, C. O., McWhirter, S. M., & Raulet, D. H. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz2738 · Cited by 268
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Aval, L. M., Pease, J. E., Sharma, R., & Pinato, D. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103323 · Cited by 253
The STING1 network regulates autophagy and cell death
Zhang, R., Kang, R., & Tang, D. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00613-4 · Cited by 266
Loo, T. M., Miyata, K., Tanaka, Y., & Takahashi, A. (2020) · Cancer Science · doi:10.1111/cas.14266 · Cited by 232
Li, X., Khorsandi, S., Wang, Y., Santelli, J., Huntoon, K. M., Nguyen, N., Yang, M., Lee, D., Lü, Y., Gao, R., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01134-z · Cited by 217
Zhang, Z., Zhou, H., Ouyang, X., Dong, Y., Sarapultsev, A., Luo, S., & Hu, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01252-z · Cited by 222
The interactions between cGAS-STING pathway and pathogens
Cheng, Z., Dai, T., He, X., Zhang, Z., Xie, F., Wang, S., Zhang, L., & Zhou, F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0198-7 · Cited by 216
LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP
Lahey, L. J., Mardjuki, R. E., Wen, X., Hess, G. T., Ritchie, C., Carozza, J. A., Böhnert, V., Maduke, M. C., Bassik, M. C., & Li, L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.021 · Cited by 201
Self-citationMitochondria-Striking a balance between host and endosymbiont
Youle, R. J. (2019) · Science · doi:10.1126/science.aaw9855 · Cited by 199
The cGAS/STING Pathway: A Novel Target for Cancer Therapy
Gan, Y., Li, X., Han, S., Liang, Q., Ma, X., Rong, P., Wang, W., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795401 · Cited by 194
Old dogs, new trick: classic cancer therapies activate cGAS
Yum, S., Li, M., & Chen, Z. J. (2020) · Cell Research · doi:10.1038/s41422-020-0346-1 · Cited by 184
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications
Shen, M., Jiang, X., Qiu, P., Oyang, L., Ren, Z., Wang, J., Peng, M., Zhou, Y., Deng, X., & Liao, Q. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01691-5 · Cited by 210
Targeting STING to promote antitumor immunity
Chin, E. N., Sulpizio, A., & Lairson, L. L. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.06.010 · Cited by 170
The balance of STING signaling orchestrates immunity in cancer
Lanng, K. R. B., Lauridsen, E. L., & Jakobsen, M. R. (2024) · Nature Immunology · doi:10.1038/s41590-024-01872-3 · Cited by 179
Cordova, A. F., Ritchie, C., Böhnert, V., & Li, L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00440 · Cited by 157
Self-citationESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling
Gentili, M., Liu, B., Papanastasiou, M., Dele-Oni, D. O., Schwartz, M. A., Carlson, R. J., Al’Khafaji, A. M., Krug, K., Brown, A., Doench, J. G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36132-9 · Cited by 151
Regulation of the cGAS-STING Pathway
Zhang, B., Xu, P., & Ablasser, A. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-032910 · Cited by 164
Small but mighty: the causes and consequences of micronucleus rupture
Kwon, M., Leibowitz, M. L., & Lee, J. H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00529-z · Cited by 149
ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP
Maltbaek, J. H., Cambier, S., Snyder, J. M., & Stetson, D. B. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.006 · Cited by 132
ENPP1’s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling
Carozza, J. A., Cordova, A. F., Brown, J. A., AlSaif, Y., Böhnert, V., Cao, X., Mardjuki, R. E., Skariah, G. M., Fernández, D., & Li, L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119189119 · Cited by 131
Self-citationBiochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 123
Self-citationMitochondrial Quality Control and Restraining Innate Immunity
Moehlman, A. T., & Youle, R. J. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-021820-101354 · Cited by 125
Carozza, J. A., Brown, J. A., Böhnert, V., Fernández, D., AlSaif, Y., Mardjuki, R. E., Smith, M. A., & Li, L. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.07.007 · Cited by 116
Self-citationChromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Flynn, P. J., Koch, P. D., & Mitchison, T. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103585118 · Cited by 118
Lv, H., Zong, Q., Chen, C., Lv, G., Xiang, W., Xing, F., Jiang, G., Yan, B., Sun, X., Ma, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43743-9 · Cited by 117
Methionine synthase is essential for cancer cell proliferation in physiological folate environments
Sullivan, M. R., Darnell, A. M., Reilly, M. F., Kunchok, T., Joesch-Cohen, L. M., Rosenberg, D. W., Ali, A., Rees, M. G., Roth, J. A., Lewis, C. A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00486-5 · Cited by 120
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Kitajima, S., Tani, T., Springer, B. F., Campisi, M., Osaki, T., Haratani, K., Chen, M., Knelson, E. H., Mahadevan, N. R., Ritter, J., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.015 · Cited by 107
The Druggability of Solute Carriers
Wang, W., Gallo, L. H., Jadhav, A. M., Hawkins, R., & Parker, C. G. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01237 · Cited by 113
Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases
Okude, H., Ori, D., & Kawai, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625833 · Cited by 104
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 102
Wei, X., Zhang, L., Yang, Y., Hou, Y., Xu, Y., Wang, Z., Su, H., Han, F., Han, J., Liu, P., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110880 · Cited by 103
cGAS-STING pathway in oncogenesis and cancer therapeutics
Hoong, B. Y. D., Gan, Y., Liu, H., & Chen, E. S. (2020) · Oncotarget · doi:10.18632/oncotarget.27673 · Cited by 106
Andrade, B., Jara‐Gutiérrez, C., Paz-Araos, M., Vázquez, M. C., Díaz, P., & Murgas, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315182 · Cited by 96
Nucleic Acid Sensors as Therapeutic Targets for Human Disease
McWhirter, S. M., & Jefferies, C. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.004 · Cited by 91
ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer
Wang, S., Böhnert, V., Joseph, A. J., Sudaryo, V., Skariah, G. M., Swinderman, J. T., Yu, F. B., Subramanyam, V., Wolf, D. M., Lyu, X., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2313693120 · Cited by 102
Self-citationMitochondrial dysfunction in astrocytes: A role in Parkinson’s disease?
Bantle, C. M., Hirst, W. D., Weihofen, A., & Shlevkov, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608026 · Cited by 95
Ying, X., Chen, Q., Yang, Y., Wu, Z., Zeng, W., Miao, C., Huang, Q., & Ai, K. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02186-6 · Cited by 87
Su, T., Cheng, F., Qi, J., Zhang, Y. X., Zhou, S., Mei, L., Fu, S., Zhang, F., Lin, S., & Zhu, G. (2022) · Advanced Science · doi:10.1002/advs.202201895 · Cited by 78
CBASS to cGAS-STING: The Origins and Mechanisms of Nucleotide Second Messenger Immune Signaling
Slavik, K. M., & Kranzusch, P. J. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-115636 · Cited by 87
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
Sun, W. Y., Liu, R., Gao, X., Lin, Z., Tang, H., Cui, H., & Zhao, E. (2023) · Biomarker Research · doi:10.1186/s40364-023-00487-4 · Cited by 83
Regulation of cGAS and STING signaling during inflammation and infection
Chauvin, S. D., Stinson, W. A., Platt, D. J., Poddar, S., & Miner, J. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104866 · Cited by 77
ENPP1 Immunobiology as a Therapeutic Target
de Córdoba, B. R., Martínez‐Monge, R., & Lecanda, F. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1681 · Cited by 79
STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells
Lu, L., Yang, C., Zhou, X., Wu, L., Hong, X., Li, W., Wang, X., Yang, Y., Cao, D., Zhang, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113108 · Cited by 81
Conserved strategies for pathogen evasion of cGAS–STING immunity
Eaglesham, J. B., & Kranzusch, P. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.04.002 · Cited by 75
cGAMP-activated cGAS–STING signaling: its bacterial origins and evolutionary adaptation by metazoans
Patel, D. J., Yu, Y., & Xie, W. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00933-9 · Cited by 79
The Evolution of STING Signaling and Its Involvement in Cancer
Vashi, N., & Bakhoum, S. F. W. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.12.010 · Cited by 72
Double-edged effects of interferons on the regulation of cancer-immunity cycle
Zhang, X., Wang, S., Zhu, Y., Zhang, M., Zhao, Y., Yan, Z., Wang, Q., & Li, X. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1929005 · Cited by 80
Zhang, Y., Zou, M., Wu, H., Zhu, J., & Jin, T. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106710 · Cited by 75
Solute carrier transporters: emerging central players in tumour immunotherapy
Chen, R., & Chen, L. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.002 · Cited by 69
Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses
Pépin, G., Nardo, D. D., Rootes, C. L., Ullah, T. R., Al-Asmari, S. S., Balka, K. R., Li, H., Quinn, K. M., Moghaddas, F., Chappaz, S., et al. (2020) · mBio · doi:10.1128/mbio.03187-19 · Cited by 69
T Cell Co-stimulation and Functional Modulation by Innate Signals
Imanishi, T., & Saito, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.003 · Cited by 67
Methotrexate recognition by the human reduced folate carrier SLC19A1
Wright, N. A., Fedor, J. G., Zhang, H., Jeong, P., Suo, Y., Yoo, J., Hong, J., Im, W., & Lee, S. (2022) · Nature · doi:10.1038/s41586-022-05168-0 · Cited by 66
Self-DNA Sensing in Lung Inflammatory Diseases
Benmerzoug, S., Ryffel, B., Togbe, D., & Quesniaux, V. F. J. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.001 · Cited by 65
Genito, C. J., Batty, C. J., Bachelder, E. M., & Ainslie, K. M. (2020) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000041 · Cited by 66
STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges
Yang, K., Tang, Z., Xing, C., & Yan, N. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.014 · Cited by 63
cGAS/STING signalling pathway in senescence and oncogenesis
Yu, L., & Liu, P. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.08.007 · Cited by 67
Regulation of cGAS‐Mediated Immune Responses and Immunotherapy
Saeed, A. F. U. H., Ruan, X., Guan, H., Su, J., & Ouyang, S. (2020) · Advanced Science · doi:10.1002/advs.201902599 · Cited by 60
Molecular and spatial mechanisms governing STING signalling
Balka, K. R., & Nardo, D. D. (2020) · FEBS Journal · doi:10.1111/febs.15640 · Cited by 60
Eaglesham, J. B., McCarty, K. L., & Kranzusch, P. J. (2020) · eLife · doi:10.7554/elife.59753 · Cited by 58
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
Yu, Y., Liu, J., Liu, C., Liu, R., Liu, L., Yu, Z., Zhuang, J., & Sun, C. (2022) · Cells · doi:10.3390/cells11193043 · Cited by 59
cGAS–STING signalling in cancer: striking a balance with chromosomal instability
Beernaert, B., & Parkes, E. E. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220838 · Cited by 60
STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
Guerini, D. (2022) · Cells · doi:10.3390/cells11071159 · Cited by 57
Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS‐STING Signaling
An, Y., Zhu, J., Xie, Q., Feng, J., Gong, Y., Fan, Q., Cao, J., Huang, Z., Shi, W., Lin, Q., et al. (2024) · Advanced Science · doi:10.1002/advs.202308131 · Cited by 55
Supply and demand: Cellular nutrient uptake and exchange in cancer
Papalazarou, V., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.026 · Cited by 53
The role of cGAS/STING in intestinal immunity
Wottawa, F., Bordoni, D., Baran, N., Rosenstiel, P. C., & Aden, K. (2021) · European Journal of Immunology · doi:10.1002/eji.202048777 · Cited by 55
The interplay between autophagy and cGAS-STING signaling and its implications for cancer
Schmid, M., Fischer, P., Engl, M., Widder, J., Gruber, S., & Slade, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356369 · Cited by 61
Regulation and inhibition of the DNA sensor cGAS
Hertzog, J., & Rehwinkel, J. (2020) · EMBO Reports · doi:10.15252/embr.202051345 · Cited by 52
cGAS-STING signaling pathway in intestinal homeostasis and diseases
Yang, Y., Wang, L., Peugnet-González, I., Parada‐Venegas, D., Dijkstra, G. D. H., & Faber, K. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1239142 · Cited by 51
Crystal structures of human ENPP1 in apo and bound forms
Dennis, M. L., Newman, J. M., Dolezal, O., Hattarki, M. K., Surjadi, R. N., Nuttall, S. D., Pham, T. M., Nebl, T., Camerino, M. A., Khoo, P. S., et al. (2020) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798320010505 · Cited by 49
Recognition of cyclic dinucleotides and folates by human SLC19A1
Zhang, Q., Zhang, X., Zhu, Y., Sun, P., Zhang, L., Ma, J., Zhang, Y., Zeng, L., Nie, X., Gao, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-05452-z · Cited by 50
cGAMP the travelling messenger
Blest, H. T. W., & Chauveau, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150705 · Cited by 57
Cyclic dinucleotides at the forefront of innate immunity
Zaver, S. A., & Woodward, J. J. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.12.004 · Cited by 50
TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
Dayoub, A. S., & Brekken, R. A. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0521-5 · Cited by 49
Mekers, V. E., Kho, V. M., Ansems, M., & Adema, G. J. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.07.014 · Cited by 47
Bharadwaj, R., Lusi, C. F., Mashayekh, S., Nagar, A., Subbarao, M., Kane, G. I., Wodzanowski, K. A., Brown, A. R., Okuda, K., Monahan, A., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.04.001 · Cited by 50
Metadata
- Authors
- Ritchie, C., Cordova, A. F., Hess, G. T., Bassik, M. C., & Li, L.
- Affiliations
- Stanford University (US)
- Stanford Medicine (US)
- Corresponding author
- Li, Lingyin
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 75
- Issue
- 2
- Pages
- 372-381.e5
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC6711396
- OpenAlex
- W2952481556
- Cited by
- 333
- References
- 44
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 49 · 2023: 55 · 2022: 53 · 2021: 46 · 2020: 47 · 2019: 10
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5R00CA19089, DP2HD084069, DP2CA228044, 2T32GM007365, 5T32GM007276)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Keywords
- SLC19A1, cGAMP, STING pathway, STING agonist, cancer immunotherapy, membrane transport, antitumor immunity
- MeSH terms
- STING Protein, Cell Membrane, Humans, Immunity, Innate, Membrane Proteins, Neoplasms, Nucleotides, Cyclic, Signal Transduction, Genome, Human, Cell Line, Tumor, Reduced Folate Carrier Protein, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review